Conclusion: The different types and doses (intermittent or once monthly total dose) of IVI treatments are well tolerated without negative effects on the markers of lipid and protein oxidation and inflammatory indices in chronic HD patients.
PMID: 22307439 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)